These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6161021)

  • 1. Antiproliferative effect on interferon on a Burkitt's lymphoma cell line.
    Leandersson T; Lundgren E
    Exp Cell Res; 1980 Dec; 130(2):421-6. PubMed ID: 6161021
    [No Abstract]   [Full Text] [Related]  

  • 2. Noncycling tumor cells are sensitive targets for the antiproliferative activity of human interferon.
    Horoszewicz JS; Leong SS; Carter WA
    Science; 1979 Nov; 206(4422):1091-3. PubMed ID: 493995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell growth regulation during density inhibition and interferon treatment.
    Leandersson T; Lundgren E
    Exp Cell Res; 1982 Mar; 138(1):167-74. PubMed ID: 6175527
    [No Abstract]   [Full Text] [Related]  

  • 4. Proliferation inhibitory effect of human alpha interferon on primary explants of Burkitt lymphoma: inverse relationship to patient survival.
    Ernberg I; Einhorn S; Strander H; Klein G
    Biomedicine; 1981 Nov; 35(6):190-3. PubMed ID: 6175356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antiproliferative effect of interferon inducers].
    Lavrukhina LA; Ershov FI
    Vopr Virusol; 1985; 30(4):446-9. PubMed ID: 2414927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ki-67 as a marker for cell cycle regulation by interferon.
    Lundblad D; Landberg G; Roos G; Lundgren E
    Anticancer Res; 1991; 11(6):2131-6. PubMed ID: 1723263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phorbol ester-induced inhibition of proliferation of Daudi Burkitt's lymphoma cells by impairment of cytokinesis.
    Menaya J; Clemens MJ
    Exp Cell Res; 1991 Jun; 194(2):260-6. PubMed ID: 2026178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral effects of interferon on a somatic cell hybrid between two Burkitt's lymphoma cell lines of different interferon sensitivities.
    Lidin B; Lamon EW
    Infect Immun; 1982 May; 36(2):847-9. PubMed ID: 6177642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glyoxalase activity and cell proliferation in Burkitt's lymphoma and transformed lymphoblast cells in vitro.
    Hooper NI; Tisdale MJ; Thornalley PJ
    Cell Mol Biol; 1988; 34(4):399-405. PubMed ID: 3219692
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative antiproliferative activity in vitro of natural interferons alpha and beta for diploid and transformed human cells.
    Borden EC; Hogan TF; Voelkel JG
    Cancer Res; 1982 Dec; 42(12):4948-53. PubMed ID: 7139598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-induced alterations in membrane functions and the growth of Daudi lymphoma and Friend leukemia cells.
    Siegler E; Schaefer A; Bilello JA
    Biosci Rep; 1982 Aug; 2(8):605-8. PubMed ID: 6182931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal proteins HMG-14 and HMG-17 are synthesized throughout the S-phase in Burkitt's lymphoma.
    Morton RL; David H; O'Connor PM; Bustin M
    Biochem Biophys Res Commun; 1996 May; 222(2):368-73. PubMed ID: 8670211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is interferon tissue specific?- Effect of human leukocyte and fibroblast interferons on the growth of lymphoblastoid and osteosarcoma cell lines.
    Einhorn S; Strander H
    J Gen Virol; 1977 Jun; 35(3):573-7. PubMed ID: 267737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cationic lipids reduce time and dose of c-myc antisense oligodeoxynucleotides required to specifically inhibit Burkitt's lymphoma cell growth.
    Williams SA; Chang L; Buzby JS; Suen Y; Cairo MS
    Leukemia; 1996 Dec; 10(12):1980-9. PubMed ID: 8946941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis and restriction of G(1)/S cell cycle by fenretinide in Burkitt's lymphoma mutu I cell line accessed with bcl-6 down-regulation.
    Hsieh T; Wu JM
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1295-301. PubMed ID: 11027625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes.
    Rapoport AP; Simons-Evelyn M; Chen T; Sidell R; Luhowskyj S; Rosell K; Obrig T; Hicks D; Hinkle PM; Nahm M; Insel RA; Abboud CN
    Blood Cells Mol Dis; 2001; 27(3):610-24. PubMed ID: 11482875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis.
    Guedez L; McMarlin AJ; Kingma DW; Bennett TA; Stetler-Stevenson M; Stetler-Stevenson WG
    Am J Pathol; 2001 Apr; 158(4):1207-15. PubMed ID: 11290537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the proliferation kinetics of Burkitt's lymphoma cells.
    Woo KB; Funkhouser WK; Sullivan C; Alabaster O
    Cell Tissue Kinet; 1980 Nov; 13(6):591-604. PubMed ID: 7417976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-proliferative effects of interferons on Daudi Burkitt lymphoma cells: induction of cell differentiation and loss of response to autocrine growth factors.
    Exley R; Gordon J; Nathan P; Walker L; Clemens MJ
    Int J Cancer; 1987 Jul; 40(1):53-7. PubMed ID: 2439466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of tumor betrayal: biphasic effects of TIMP-1 on Burkitt's lymphoma.
    Yan L; Moses MA
    Am J Pathol; 2001 Apr; 158(4):1185-90. PubMed ID: 11290534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.